Harrow Health, Inc. (HROW)

USD 22.08

(-6.12%)

Long Term Debt Summary of Harrow Health, Inc.

  • Harrow Health, Inc.'s latest annual long term debt in 2023 was 183.17 Million USD , up 75.83% from previous year.
  • Harrow Health, Inc.'s latest quarterly long term debt in 2024 Q2 was 185.02 Million USD , up 0.48% from previous quarter.
  • Harrow Health, Inc. reported annual long term debt of 104.17 Million USD in 2022, up 34.11% from previous year.
  • Harrow Health, Inc. reported annual long term debt of 77.67 Million USD in 2021, up 307.81% from previous year.
  • Harrow Health, Inc. reported quarterly long term debt of 185.02 Million USD for 2024 Q2, up 0.48% from previous quarter.
  • Harrow Health, Inc. reported quarterly long term debt of 182.18 Million USD for 2023 Q3, up 7.35% from previous quarter.

Annual Long Term Debt Chart of Harrow Health, Inc. (2023 - 2006)

Historical Annual Long Term Debt of Harrow Health, Inc. (2023 - 2006)

Year Long Term Debt Long Term Debt Growth
2023 183.17 Million USD 75.83%
2022 104.17 Million USD 34.11%
2021 77.67 Million USD 307.81%
2020 19.04 Million USD 2.5%
2019 18.58 Million USD 54.87%
2018 11.99 Million USD -18.53%
2017 14.72 Million USD 59.14%
2016 9.25 Million USD 11.01%
2015 8.33 Million USD 43852.97%
2014 18.96 Thousand USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD -100.0%
2010 1.05 Million USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Long Term Debt Comparison of Harrow Health, Inc.

Name Long Term Debt Long Term Debt Difference
Cosmos Health Inc. 3.03 Million USD -5934.643%
Safety Shot Inc 304.9 Thousand USD -59974.711%
Bright Green Corporation 201.78 Thousand USD -90676.725%
Embecta Corp. 1.62 Billion USD 88.731%
ANI Pharmaceuticals, Inc. 309.66 Million USD 40.849%
Aquestive Therapeutics, Inc. 91.07 Million USD -101.12%
Collegium Pharmaceutical, Inc. 489.96 Million USD 62.615%
Dynavax Technologies Corporation 252.41 Million USD 27.433%
Esperion Therapeutics, Inc. 501.54 Million USD 63.479%
Intra-Cellular Therapies, Inc. 13.32 Million USD -1274.546%
Pacira BioSciences, Inc. 513.79 Million USD 64.349%
PainReform Ltd. 30 Thousand USD -610473.333%
Sunshine Biopharma, Inc. 539.03 Thousand USD -33881.467%
Sunshine Biopharma, Inc. 539.03 Thousand USD -33881.467%
SCYNEXIS, Inc. 12.15 Million USD -1406.473%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD -156284.841%
Journey Medical Corporation 14.62 Million USD -1152.715%
Alpha Teknova, Inc. 13.25 Million USD -1282.326%
Procaps Group, S.A. 28.41 Million USD -544.745%
Theratechnologies Inc. 51.26 Million USD -257.332%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD -210442.529%
Biofrontera Inc. 804 Thousand USD -22682.587%
DURECT Corporation 2.7 Million USD -6679.127%
Supernus Pharmaceuticals, Inc. 33.19 Million USD -451.789%
Cronos Group Inc. 1.55 Million USD -11649.326%
OptiNose, Inc. 611 Thousand USD -29879.051%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 63.241%
Kala Pharmaceuticals, Inc. 34.19 Million USD -435.747%
RedHill Biopharma Ltd. 455 Thousand USD -40157.582%
Organogenesis Holdings Inc. 60.74 Million USD -201.543%
Guardion Health Sciences, Inc. - USD -Infinity%
Cumberland Pharmaceuticals Inc. 12.78 Million USD -1332.806%
Radius Health, Inc. 339.66 Million USD 46.073%
Universe Pharmaceuticals INC - USD -Infinity%
ProPhase Labs, Inc. 10.25 Million USD -1685.65%
Phibro Animal Health Corporation 458.28 Million USD 60.031%
Procaps Group S.A. 28.41 Million USD -544.745%
Alvotech 1.02 Billion USD 82.178%
TherapeuticsMD, Inc. 6.53 Million USD -2704.225%
Viatris Inc. 16.18 Billion USD 98.868%
Rockwell Medical, Inc. 8.29 Million USD -2108.755%
Aytu BioPharma, Inc. 10.87 Million USD -1584.031%
SIGA Technologies, Inc. 335.99 Thousand USD -54416.936%
Tilray Brands, Inc. 287.93 Million USD 36.384%
Lifecore Biomedical, Inc. 120.51 Million USD -51.997%
Shineco, Inc. 10.01 Million USD -1728.551%
PetIQ, Inc. 437.82 Million USD 58.163%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 210 Thousand USD -87124.762%
Neurocrine Biosciences, Inc. 258.3 Million USD 29.086%
Alimera Sciences, Inc. 64.48 Million USD -184.036%
Silver Spike Investment Corp. - USD -Infinity%
Assertio Holdings, Inc. 38.51 Million USD -375.598%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD -135493.572%
Petros Pharmaceuticals, Inc. 6.85 Million USD -2571.172%
Clever Leaves Holdings Inc. 720 Thousand USD -25340.556%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -814577.104%
Avadel Pharmaceuticals plc 32.75 Million USD -459.133%
Hempacco Co., Inc. 5.93 Million USD -2988.383%
Talphera, Inc. - USD -Infinity%
Alvotech 1.02 Billion USD 82.178%
Eagle Pharmaceuticals, Inc. 56.21 Million USD -225.836%
Lantheus Holdings, Inc. 616.12 Million USD 70.27%
Currenc Group, Inc. 2.5 Million USD -7206.498%
Kamada Ltd. 7.43 Million USD -2362.651%
Indivior PLC 235.66 Million USD 22.275%
Evoke Pharma, Inc. 5 Million USD -3563.44%
Flora Growth Corp. 942 Thousand USD -19345.011%
Cyclo Therapeutics, Inc. 22.48 Thousand USD -814577.104%
Evolus, Inc. 120.35 Million USD -52.188%
HUTCHMED (China) Limited 48.18 Million USD -280.112%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 68.912%
Akanda Corp. 2.49 Million USD -7235.227%